Sequenom Inc. Reports Financial Results for the Fourth Quarter and Full Year of 2012

Published: Mar 08, 2013

SAN DIEGO, March 7, 2013 /PRNewswire/ -- Sequenom, Inc. (SQNM), a life sciences company providing innovative genetic analysis solutions, today reported total revenues of $33.7 million and $89.7 million for the fourth quarter and full year of 2012, respectively. Net loss was $32.8 million, or $0.29 per share, and $117.1 million, or $1.03 per share, for the fourth quarter and full year, respectively.

Back to news